About
Striving to improve and extend patients’ lives
Blueprint Medicines, a Sanofi company, is a global
biopharmaceutical company that invents life-changing
medicines. We seek to improve and extend patients' lives
by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology.
With two approved medicines and a broad pipeline of investigational therapies, we have a proven track record of discovering, developing and commercializing innovative therapies that target root causes of disease. Our approach combines deep expertise in biology, world-class drug design capabilities and robust clinical development and commercial capabilities and infrastructure.
In recent years, we have significantly evolved our scientific platform to expand beyond kinase inhibitors to additional modalities, including targeted protein degradation, and incorporate state-of-the-art translational medicine capabilities and new technologies, including artificial intelligence and machine learning tools, to enhance the productivity and efficiency of our drug discovery efforts.
Today, we are advancing a diverse portfolio of innovative therapies for mast cell disorders, including systemic mastocytosis and chronic urticaria, and cancer, including breast cancer and other solid tumors.
